Topoisomerase II Alpha Expression in Testicular Germ Cell Tumors
Authors:
- Debra L. ZyngerDZDebra L. Zynger
- Chuanyan LuanCLChuanyan Luan
- James M. KozlowskiJKJames M. Kozlowski
- Ximing J. YangXYXiming J. Yang
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Etoposide, Topoisomerase II and CancerCurrent Medicinal Chemistry - Anti-Cancer Agents, 2005
- Residual Tumor Resection After High-Dose Chemotherapy in Patients With Relapsed or Refractory Germ Cell CancerJournal of Clinical Oncology, 2004
- Topoisomerase II: untangling its contribution at the centromereChromosome Research, 2004
- Gene Expression Profiling of Early- and Late-Relapse Nonseminomatous Germ Cell Tumor and Primitive Neuroectodermal Tumor of the TestisClinical Cancer Research, 2004
- DNA Topoisomerases: Structure, Function, and MechanismAnnual Review of Biochemistry, 2001
- DNA topoisomerase expression in tumors—a novel target for chemotherapyHuman Pathology, 2000
- RETROPERITONEAL LYMPH NODE DISSECTION FOR THE MANAGEMENT OF CLINICAL STAGE I NONSEMINOMAJournal of Urology, 2000
- Differential effects of all-trans -retinoic acid, docosahexaenoic acid, and hexadecylphosphocholine on cisplatin-induced cytotoxicity and apoptosis in a cisplantin-sensitive and resistant human embryonal carcinoma cell lineCancer Chemotherapy and Pharmacology, 1998
- Testicular Germ-Cell CancerNew England Journal of Medicine, 1997
- Late relapse of testicular cancer.Journal of Clinical Oncology, 1995